Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT)

Price$0.99

Favorite Metrics

Price vs S&P 500 (26W)-72.60%

Price vs S&P 500 (4W)30.01%

Market Capitalization$6.95M

P/E Ratio (Annual)28.65x

All Metrics

P/CF (Annual)7.90x

Book Value / Share (Quarterly)$0.92

P/TBV (Annual)5.68x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)854.84%

Cash Flow / Share (Quarterly)$-0.00

Payout Ratio (TTM)78.85%

Price vs S&P 500 (YTD)-18.01%

Gross Margin (TTM)44.51%

Net Profit Margin (TTM)-4.16%

EPS (TTM)$-0.03

10-Day Avg Trading Volume0.03M

EPS Excl Extra (TTM)$-0.03

EPS (Annual)$0.04

Dividend / Share (Annual)$0.05

ROI (Annual)3.05%

Gross Margin (Annual)48.99%

Cash / Share (Quarterly)$0.15

Revenue Growth QoQ (YoY)53240.18%

P/E Normalized (Annual)28.65x

ROA (Last FY)2.29%

EBITD / Share (TTM)$0.04

Operating Margin (TTM)-5.00%

Cash Flow / Share (Annual)$0.04

P/B Ratio1.08x

P/B Ratio (Quarterly)6.42x

Net Income / Employee (Annual)$0

Net Interest Coverage (TTM)5.59x

ROA (TTM)-2.08%

EPS Incl Extra (Annual)$0.04

Current Ratio (Annual)1.31x

Quick Ratio (Quarterly)0.83x

3-Month Avg Trading Volume0.15M

52-Week Price Return-87.00%

EV / Free Cash Flow (Annual)27.44x

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.85

P/S Ratio (Annual)1.74x

Asset Turnover (Annual)0.38x

52-Week High$14.30

EPS Excl Extra (Annual)$0.04

26-Week Price Return-63.85%

Quick Ratio (Annual)0.80x

13-Week Price Return-11.56%

Total Debt / Equity (Annual)0.30x

Current Ratio (Quarterly)1.49x

Enterprise Value$53.272

Asset Turnover (TTM)0.50x

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)1.63x

Pretax Margin (Annual)7.72%

Cash / Share (Annual)$0.06

3-Month Return Std Dev160.07%

Net Income / Employee (TTM)$-0

ROE (Last FY)3.98%

Net Interest Coverage (Annual)-1.92x

EPS Basic Excl Extra (Annual)$0.04

Receivables Turnover (TTM)3.29x

Total Debt / Equity (Quarterly)0.29x

EPS Incl Extra (TTM)$-0.03

Receivables Turnover (Annual)2.04x

ROI (TTM)-2.74%

P/S Ratio (TTM)1.30x

Revenue / Share (Annual)$0.60

Tangible BV / Share (Annual)$0.81

Price vs S&P 500 (52W)-122.10%

Year-to-Date Return-13.87%

5-Day Price Return-17.46%

EPS Normalized (Annual)$0.04

Net Profit Margin (Annual)6.07%

Month-to-Date Return5.96%

EBITD / Share (Annual)$0.13

EPS Growth (3Y)528.02%

Operating Margin (Annual)8.82%

LT Debt / Equity (Annual)0.02x

P/CF (TTM)26.16x

LT Debt / Equity (Quarterly)0.02x

EPS Basic Excl Extra (TTM)$-0.03

P/TBV (Quarterly)6.96x

Payout Ratio (Annual)141.66%

P/B Ratio (Annual)5.23x

Dividend / Share (TTM)$0.00

Inventory Turnover (TTM)2.32x

Pretax Margin (TTM)-6.63%

Book Value / Share (Annual)$0.88

Price vs S&P 500 (13W)-14.43%

Dividend Yield (TTM)0.05%

Beta-0.64x

P/FCF (Annual)24.42x

Revenue / Share (TTM)$0.77

ROE (TTM)-3.55%

52-Week Low$0.68

About

Zhengye Biotechnology manufactures and distributes veterinary vaccines primarily for livestock, with swine and poultry vaccines generating the majority of revenue. The company offers a diverse product range including vaccines for cattle, goats, sheep, waterfowl, and pets, sold across Chinese provinces and exported to Vietnam, Pakistan, and Egypt.